Guoguo Jin | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Assoc. Prof. Dr. Guoguo Jin | Medicine and Dentistry | Best Researcher Award

Deputy Director from Key Laboratory of Chronic Disease Health Management of Henan Province, China

Dr. Guoguo Jin is an accomplished biomedical researcher specializing in the chemical prevention of tumors. With a strong foundation in pathology and bioengineering, she has steadily developed a research career that bridges cancer biology and cardiovascular complications arising from oncological treatments. Her work delves into the molecular mechanisms underlying tumorigenesis, cardiotoxicity from chemotherapeutic agents, and the identification of therapeutic targets for various cancers, particularly esophageal, gastric, and colon carcinomas. Dr. Jin currently serves as the Deputy Director of both the Key Laboratory of Chronic Disease Health Management and the Department of Scientific Research and Discipline Construction at Fuwai Central China Cardiovascular Hospital. She has led several national and provincial-level research projects and has published extensively in top-tier journals. Her research contributions are complemented by multiple patents aimed at mitigating drug-induced cardiotoxicity. Recognized for her leadership and scientific acumen, she has received accolades such as the Young and Middle-aged Academic Leader title from the Health Commission of Henan Province. Overall, Dr. Jin’s work represents a compelling blend of scientific rigor, clinical relevance, and translational potential. Her continued efforts are likely to yield significant advancements in cancer therapy and patient care.

Professional Profile

Education

Dr. Guoguo Jin began her academic journey in bioengineering, earning her Master’s degree from the School of Bioengineering at Zhengzhou University in July 2011. This foundational training equipped her with critical insights into biomedical sciences and experimental techniques. She then pursued her doctoral studies in pathology and pathophysiology at the Basic Medical College of Zhengzhou University, receiving her Ph.D. in July 2017. During her doctoral program, she was selected for an international joint training opportunity and spent two years (2015–2017) at the prestigious Hormel Institute, University of Minnesota. There, she conducted in-depth research into the signal transduction pathways related to tumorigenesis and its prevention. Her time abroad not only enriched her technical competencies but also exposed her to cutting-edge methodologies in cancer biology. This combination of local and international academic training has laid a solid foundation for her ongoing research into tumor mechanisms and therapeutic strategies. Dr. Jin’s educational background reflects a trajectory of consistent academic excellence and scientific curiosity, establishing her as a capable and knowledgeable researcher in the fields of oncology and pathology.

Professional Experience

Dr. Guoguo Jin currently holds dual leadership roles at Fuwai Central China Cardiovascular Hospital, where she serves as Deputy Director of both the Key Laboratory of Chronic Disease Health Management of Henan Province and the Department of Scientific Research and Discipline Construction. Her professional responsibilities primarily involve overseeing tumor-related research and institutional academic development. Earlier in her career, she gained international experience at the Hormel Institute, University of Minnesota, where she focused on cancer signal transduction pathways. This exposure to high-impact research environments significantly influenced her approach to scientific inquiry. Throughout her career, Dr. Jin has successfully led multiple research projects funded at both national and provincial levels. These projects explore the molecular mechanisms of drug-induced cardiotoxicity, tumor progression, and the discovery of small-molecule inhibitors. Her clinical and translational research activities are closely integrated with her hospital’s goals, enhancing the relevance and impact of her findings. With a strong blend of laboratory management, project leadership, and interdepartmental coordination, Dr. Jin’s professional journey reflects her growth from a bench scientist to an influential figure in medical research administration. Her dual roles in scientific research and academic governance enable her to contribute meaningfully to both science and institutional progress.

Research Interest

Dr. Guoguo Jin’s primary research interest lies in the chemical prevention of tumors, with a focus on uncovering the molecular mechanisms that drive carcinogenesis and treatment-related complications. She is particularly interested in the pathways that regulate tumor initiation and progression in gastrointestinal cancers such as esophageal, gastric, and colon cancer. A significant portion of her work also explores the cardiotoxic effects of chemotherapeutic agents like osimertinib and doxorubicin, aiming to develop strategies to mitigate these adverse outcomes. Her recent studies have investigated the roles of signaling molecules such as WNK1, hnRNPU, AHCY-LDHA, and ZIP8 in cancer development and progression. Dr. Jin is also deeply involved in the identification and evaluation of small-molecule inhibitors and natural compounds like α-mangostin and curcumin for their anti-tumor efficacy. Her research bridges basic science and clinical application, positioning her work at the forefront of translational oncology. Through the development of targeted therapies and predictive biomarkers, she aims to improve both treatment outcomes and quality of life for cancer patients. This integrated focus on cancer biology and cardiotoxicity underlines her commitment to advancing personalized medicine in oncology.

Research Skills

Dr. Guoguo Jin possesses a wide array of research skills, especially in molecular and cellular biology techniques relevant to oncology. She is proficient in signal transduction analysis, gene expression profiling, histone modification studies, and functional validation of oncogenes and tumor suppressors. Her expertise extends to the use of in vitro and in vivo cancer models to study the efficacy and mechanisms of chemopreventive agents. She has demonstrated a high level of competence in utilizing molecular techniques such as Western blotting, qRT-PCR, immunohistochemistry, and chromatin immunoprecipitation assays. Her postdoctoral training at the Hormel Institute allowed her to master advanced techniques for dissecting signaling pathways in cancer. In addition to experimental skills, Dr. Jin has a solid foundation in project design, grant writing, and data analysis. She is also skilled in translating laboratory findings into potential therapeutic applications, as demonstrated by her patents. Moreover, her ability to manage multidisciplinary teams and coordinate with clinical departments enhances the practical relevance of her research. These competencies enable her to effectively lead complex biomedical projects from conceptualization to execution and dissemination.

Awards and Honors

Dr. Guoguo Jin has received multiple awards and honors that underscore her impact and promise in the field of medical research. In February 2024, she was selected as a Young and Middle-aged Academic Leader in Health and Wellness by the Health Commission of Henan Province, a recognition of her leadership in translational cancer research. Later that year, she was awarded a position in the National-Level Talent Cultivation Project for First-Class Discipline in Clinical Medicine at Zhengzhou University. Dr. Jin has also secured several competitive research grants, including the National Natural Science Foundation Youth Project, the Science and Technology Tackling Project by the Department of Science and Technology of Henan Province, and the Outstanding Young Talent Training Program for Health and Technology Innovation. Her innovative research on cancer prevention and cardiotoxicity has led to two patents, further highlighting her commitment to developing clinically relevant solutions. These accolades reflect not only her scientific excellence but also her dedication to advancing health outcomes through rigorous and applied research. The consistent support from national and provincial agencies illustrates her status as a leading figure in her domain.

Conclusion

Dr. Guoguo Jin exemplifies the qualities of a leading researcher with her focused expertise in chemical tumor prevention and translational oncology. Her well-rounded background—from robust academic training to leadership in high-impact research—positions her as a valuable contributor to both the scientific community and clinical practice. Her studies on molecular mechanisms of cancer progression and cardiotoxicity have not only expanded academic understanding but have also offered practical pathways for improving patient outcomes. Through national and provincial grants, influential publications, and patented innovations, she continues to push the boundaries of cancer therapy and prevention. While her research is already making a meaningful impact, future expansion into international collaborations and clinical trials could further elevate her contributions. Overall, Dr. Jin’s career is marked by scientific rigor, visionary leadership, and a commitment to translating research into real-world solutions. She is a highly deserving candidate for recognition through honors such as the Best Researcher Award and is likely to make even greater strides in cancer research in the years to come.

Publications Top Notes

  1. Title: STIP1 drives metabolic reprogramming in esophageal squamous cell carcinoma via AHCY-LDHA axis
    Authors: Jin G, Song Y, Yan M, Fang S, Shao Y, Zhao K, Liu M, Guo Q, Jia X, Zhang C, Wang Z, Liu K, Li X, Zhao S, Guo Z, Dong Z
    Year: 2025

  2. Title: hnRNPU-mediated pathogenic alternative splicing drives gastric cancer progression
    Authors: Jin G, Song Y, Fang S, Yan M, Yang Z, Shao Y, Zhao K, Liu M, Wang Z, Guo Z, Dong Z
    Year: 2025

  3. Title: ZIP8 modulates ferroptosis to drive esophageal carcinoma progression
    Authors: Yang Z, Zhao K, Li X, Yanzhang R, Zhang H, Yu Y, Yan M, Fang S, Li T, Li H, Chu X, Han S, Zhang Z, Teng J, Jin G, Guo Z
    Year: 2025

  4. Title: Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer
    Authors: Jin G, Yan M, Liu K, Yao K, Chen H, Zhang C, Yi Y, Reddy K, Gorja DR, Laster KV, Guo Z, Dong Z
    Year: 2020

  5. Title: Ginger extract inhibits c-MET activation and suppresses osteosarcoma in vitro and in vivo
    Authors: Yanzhang R, Yan M, Yang Z, Zhang H, Yu Y, Li X, Shen R, Chu X, Han S, Zhang Z, Teng J, Li H, Li T, Jin G, Guo Z
    Year: 2025

  6. Title: PDK1-mediated phosphorylation of USP5 modulates NF-κB signalling to enhance osteosarcoma growth
    Authors: Yang Z, Yu Z, Teng J, Yanzhang R, Yu Y, Zhang H, Jin G, Wang F
    Year: 2025

  7. Title: Precision therapy for cancer prevention by targeting carcinogenesis
    Authors: Jin G, Liu K, Guo Z, Dong Z*
    Year: 2024

  8. Title: Decrypting the Molecular Mechanistic Pathways Delineating the Chemotherapeutic Potential of Ruthenium-Phloretin Complex in Colon Carcinoma Correlated with the Oxidative Status and Increased Apoptotic Events
    Authors: Jin G, Zhao Z, Chakraborty T, et al.
    Year: 2020

  9. Title: Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma
    Authors: Zhao Z, Jin G, Yao K, Liu K, Liu F, Chen H, Wang K, Gorja DR, Reddy K, Bode A.M., Guo Z, Dong Z
    Year: 2019

  10. Title: Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway
    Authors: Li D, Wang G, Jin G, Yao K, Zhao Z, Bie L, Guo Y, Li N, Deng W, Chen X, Chen B, Liu Y, Luo S, Guo Z
    Year: 2019

Kumiko Tajima | Medicine and Dentistry | Women Researcher Award

Posted on by Shen Awards

Dr. Kumiko Tajima | Medicine and Dentistry | Women Researcher Award

Manager from Gunma Central Hospital, Japan

Kumiko Tajima is a highly qualified medical professional with extensive experience in internal medicine and diabetes care. She graduated from Gunma University School of Medicine in 1992 and completed graduate studies at Gunma University Graduate School in 1999. With over two decades of clinical practice, she has served at several prominent medical institutions in Japan, including Gunma University School of Medicine, National Takasaki Hospital, and Gunma Prefectural Cardiovascular Center. Since 2014, she has been practicing at Gunma Central Hospital. Kumiko is recognized as a certified physician by the Japanese Society of Internal Medicine and specializes in general internal medicine and diabetes management. Her career is marked by a strong commitment to patient care, education, and specialized training, including roles as an instructor for medical training programs. She also serves vulnerable populations as a designated physician for disabilities and intractable diseases. While her clinical expertise is well documented, her research involvement is not explicitly detailed in the information available, suggesting a potential focus on clinical practice and medical education over research output. Nevertheless, her professional credentials and dedication to healthcare highlight her as a respected figure in the medical community.

Professional Profile

Education

Kumiko Tajima completed her formal education at Gunma University, one of Japan’s reputable institutions. She graduated from the Gunma University School of Medicine in 1992, where she acquired the foundational knowledge and clinical skills required to pursue a medical career. Following her medical degree, she advanced her expertise by completing graduate studies at Gunma University Graduate School in 1999. This postgraduate education likely included clinical research or advanced medical training, equipping her with enhanced knowledge in medical sciences. Her educational background provided a strong base for her subsequent clinical work and certifications in various medical specialties. Being an alumna of the same university for both undergraduate and graduate studies suggests continuity and depth in her academic preparation. Her education set the stage for her later roles in internal medicine, diabetes specialization, and her involvement in training programs. The rigorous training at Gunma University, known for its emphasis on both research and clinical practice, has likely influenced her professional trajectory, balancing patient care with medical education.

Professional Experience

Kumiko Tajima has accumulated significant clinical experience working in multiple prestigious medical institutions across Japan. Early in her career, she worked at Gunma University School of Medicine, which provided her with exposure to academic medicine and clinical research environments. She also served at National Takasaki Hospital, Tatebayashi Kosei Hospital, and Gunma Prefectural Cardiovascular Center, gaining diverse experience in patient care across various specialties and healthcare settings. Since 2014, she has been a key medical professional at Gunma Central Hospital, where she continues to provide specialized care in internal medicine and diabetes management. Throughout her career, she has been recognized for her expertise by multiple Japanese medical societies, reflected in her qualifications as a certified physician and specialist. She holds important roles such as a training instructor for diabetes care and general medical training, indicating her leadership in mentoring younger physicians. Additionally, her designation as a physician under the Welfare Act for the Physically Disabled and for intractable diseases highlights her involvement in public health and complex patient populations. Her extensive clinical roles demonstrate a strong foundation in both patient care and medical education.

Research Interests

While explicit details about Kumiko Tajima’s research interests are not provided in the information available, it is reasonable to infer that her research focus aligns closely with her clinical specialties—internal medicine and diabetes. Given her certifications and instructor roles within the Japan Diabetes Society, she likely engages with research related to diabetes management, treatment outcomes, and possibly public health aspects of chronic diseases. Her designation as a physician responsible for intractable diseases suggests potential interest in complex, difficult-to-treat conditions that may require innovative clinical approaches or translational research. Moreover, her role in general medical training indicates a probable interest in medical education research or clinical practice improvement. Without specific publications or ongoing research projects mentioned, her primary contributions may be in applying clinical knowledge to patient care and educating the next generation of physicians. If involved in research, it may focus on improving clinical protocols, diabetes education, or interdisciplinary care for chronic disease patients. Confirmation of such interests would strengthen her profile as a clinician-researcher.

Research Skills

Kumiko Tajima’s documented expertise suggests strong clinical skills particularly in internal medicine, diabetes care, and training future medical professionals. As a certified specialist and instructor in diabetes, she likely possesses advanced skills in managing complex cases, interpreting clinical data, and applying evidence-based medicine. Her role as an industrial physician and designated physician for the disabled reflects proficiency in occupational health and specialized patient management. Although there is no explicit mention of laboratory or bench research skills, her graduate education and clinical roles imply familiarity with clinical research methodologies, patient data analysis, and possibly clinical trial participation. Her instructional roles also suggest capabilities in curriculum development, clinical supervision, and medical education, which are important research-adjacent skills. If involved in research activities, these skills would be foundational for clinical studies, epidemiological research, or healthcare quality improvement projects. To enhance her research profile, further skills in scientific writing, grant applications, and collaboration in research networks would be beneficial.

Awards and Honors

The provided information does not list any specific awards or honors received by Kumiko Tajima. However, her qualifications as a certified physician by reputable Japanese medical societies, and her appointment as a specially appointed instructor for general medical training, indicate professional recognition within the medical community. These certifications and instructor roles can be seen as professional honors reflecting her expertise and dedication to clinical excellence and education. Additionally, her designation as a physician for intractable diseases and disabilities suggests recognition of her specialized skills and trust placed in her by public health authorities. While no formal awards are cited, her career achievements and appointments demonstrate a high level of respect and acknowledgment from her peers and regulatory bodies. Should she have received awards related to clinical innovation, research contributions, or teaching excellence, including these would enhance her profile for awards specifically focused on research.

Conclusion

Kumiko Tajima is an experienced and highly qualified medical professional with strong credentials in internal medicine and diabetes care. Her clinical expertise, long-standing service in multiple hospitals, and roles in medical training and specialized care demonstrate her dedication to both patient health and medical education. While she holds numerous certifications and leadership roles within professional medical societies, her profile lacks explicit information on research outputs, publications, or scientific contributions. For a Women Researcher Award focused on research excellence, evidence of active research involvement or scholarly achievements would be necessary to strengthen her candidacy. Nevertheless, her commitment to specialized clinical care, training, and vulnerable patient populations underscores her valuable role in the healthcare system. If supplemented by further details on her research activities, Kumiko Tajima could be a strong candidate. Currently, her profile is more aligned with clinical leadership and education, rather than research-centric recognition.

Publications Top Notes

  1. A case of SHORT syndrome with a novel genetic mutation diagnosed 19 years after the onset of diabetes

    • Authors: Kumiko Tajima, Yushi Hirota, Tomofumi Takayoshi, Wataru Ogawa

    • Year: 2025

  2. Medical Mystery: Abnormal Abdominal Radiograph — The Answer

    • Authors: Masahiko Kurabayashi, Kumiko Tajima

    • Year: 2007

  3. Medical Mystery — Abnormal Abdominal Radiograph

    • Authors: Kumiko Tajima, Masahiko Kurabayashi

    • Year: 2006

Vanina Taliercio | Health Professions | Best Researcher Award

Posted on by Shen Awards

Assist. Prof. Dr. Vanina Taliercio | Health Professions | Best Researcher Award

Faculty, MD from University of Utah, United States

Dr. Vanina L. Taliercio is a physician-scientist whose career spans clinical practice, research, and academic leadership. Currently an Assistant Professor at the University of Utah, she brings extensive expertise in pediatrics, dermatology, genetics, and biomedical informatics. Her work integrates patient care with research, particularly focusing on genetic conditions, neurofibromatosis (NF), and tuberous sclerosis complex (TSC). Dr. Taliercio holds leadership roles as Co-director of both the NF and TSC clinics and serves as Associate Program Director for medical genetics and pediatrics/genetics programs. Her background includes significant contributions to national health initiatives, such as improving medication distribution systems for Hansen’s Disease in Argentina. In research, she has published several papers and presented at international conferences, particularly in dermatology and health informatics. Dr. Taliercio’s multidisciplinary approach, combining clinical insight with data-driven research, makes her a dynamic and impactful contributor to academic medicine. She is committed to advancing patient care, improving health outcomes, and mentoring the next generation of medical professionals.

Professional Profile

Education

Dr. Vanina Taliercio earned her Doctor of Medicine (MD) degree from Universidad del Salvador, Argentina, in 2002. To deepen her research expertise, she pursued a Master of Science (MS) in Biomedical Informatics at Oregon Health & Science University in 2012. Her postgraduate medical training is extensive and diverse. She completed a pediatrics residency at Pedro de Elizalde Hospital in Buenos Aires from 2003 to 2007, followed by a pediatric dermatology fellowship at Ramos Mejía Hospital from 2012 to 2015. After relocating to the United States, she undertook an ACGME residency in pediatrics at the University of Utah from 2020 to 2021, and most recently completed a medical genetics fellowship at the University of Utah between 2021 and 2023. This broad educational journey has equipped her with a unique combination of clinical and research expertise across multiple disciplines, positioning her well for leadership roles in academic medicine.

Professional Experience

Dr. Taliercio’s professional career spans several important roles in both Argentina and the United States. She began as a pediatrician at Hospital Italiano de Buenos Aires and OSDE, providing care to infants and children. She then worked as a clinical data research analyst, focusing on electronic health records, data reconciliation, and healthcare quality indicators, which led to key publications. At the national level, she contributed to Argentina’s Leprosy National Program, overseeing WHO medication distribution, developing national disease statistics, and creating educational materials to reduce stigma. Since moving to the United States, Dr. Taliercio has served as an Assistant Professor at the University of Utah, providing outpatient and inpatient care for patients with genetic and metabolic conditions. In addition, she co-directs two specialized clinics and supports the development of medical education programs as an Associate Program Director. Her career reflects a commitment to integrating clinical service, research, and academic leadership to improve patient care and healthcare systems.

Research Interests

Dr. Taliercio’s research interests span dermatology, genetics, pediatrics, and biomedical informatics. Her work has focused on psoriasis, alopecia, neurocutaneous disorders such as neurofibromatosis and tuberous sclerosis complex, and patient-reported outcomes. She is also interested in leveraging electronic health records and healthcare information systems to improve clinical decision-making and healthcare quality. Earlier in her career, she contributed to the development of mortality registries and national health databases, demonstrating a strong interest in population-level health outcomes and system-wide improvements. Her interdisciplinary approach combines clinical insights with data analysis, aiming to translate research findings into practical interventions that enhance patient care. She is particularly interested in collaborative, cross-disciplinary projects that bridge clinical practice with informatics tools and public health strategies.

Research Skills

Dr. Taliercio brings a broad set of research skills honed through years of clinical and academic work. She has expertise in clinical research design, data extraction and analysis from electronic health records, and the development of clinical research informatics tools. She has authored and co-authored several peer-reviewed publications and presented her work at national and international conferences. Dr. Taliercio has experience in conducting patient-reported outcomes research, implementing quality indicators in healthcare systems, and contributing to the development of national health guidelines. She also has teaching experience, having helped develop courses in clinical research and epidemiology. Her multidisciplinary training has given her strong analytical abilities, a deep understanding of clinical workflows, and the ability to bridge gaps between clinical practice and research. She is skilled at working collaboratively with clinicians, researchers, and informaticians to bring projects from concept to implementation.

Awards and Honors

While Dr. Taliercio’s profile highlights a range of accomplishments, formal details on specific research awards or honors are not explicitly listed. However, her leadership roles and appointments—such as Assistant Professor, Co-director of the NF and TSC clinics, and Associate Program Director—reflect strong recognition by her institution and peers. Additionally, her international career trajectory, moving from national public health leadership in Argentina to academic medicine in the United States, speaks to her professional reputation and the trust placed in her abilities. Her contributions to national guidelines on Hansen’s Disease in Argentina and her involvement in major research projects in dermatology and informatics show that she is regarded as a valuable collaborator and leader in her fields. Documenting formal research awards, grants, or recognitions in future applications would further strengthen this section.

Conclusion

In summary, Dr. Vanina Taliercio is a dedicated and accomplished physician-scientist who has made significant contributions across multiple disciplines, including dermatology, genetics, pediatrics, and biomedical informatics. Her career is marked by a unique combination of clinical service, research productivity, and academic leadership. She has consistently demonstrated a commitment to improving patient care, advancing medical knowledge, and mentoring students and trainees. While her profile would benefit from additional emphasis on independent research leadership and formal recognitions, she is clearly a rising figure in her field with the potential for even greater impact. Dr. Taliercio is a strong candidate for research-focused awards and honors, reflecting her broad expertise, international experience, and dedication to translational medicine. Continued pursuit of large-scale research projects, funding opportunities, and international collaborations will further enhance her academic and professional profile.

Publications Top Notes

  • Title: Worth the Effort: Lessons for Discovery and Care From an Unusual Case of Gorlin Syndrome
    Journal: American Journal of Medical Genetics Part A
    Date: 2025-05-03
    DOI: 10.1002/ajmg.a.64108
    Contributors: V. Taliercio; J. Zhao; S. E. Boyden; R. Mao; P. Bayrak‐Toydemir; A. Pflaum; J. Palumbos; A. Andrews; E. E. Baldwin; C. Welt et al.

  • Title: Quality of Life Among Family of Patients with Atopic Dermatitis and Psoriasis
    Journal: International Journal of Behavioral Medicine
    Date: 2023-06
    DOI: 10.1007/s12529-022-10104-7
    Contributors: Ashley M. Snyder; Adelheid U. Brandenberger; Vanina L. Taliercio; Bianca E. Rich; Lisa B. Webber; Abram P. Beshay; Joshua E. Biber; Rachel Hess; Jamie L. W. Rhoads; Aaron M. Secrest

  • Title: Effects of Pain From Atopic Dermatitis: Interview and Focus Group Study With Patients and Their Families
    Journal: JMIR Dermatology
    Date: 2021-10-04
    DOI: 10.2196/29826
    Contributors: Ashley M. Snyder; Vanina L. Taliercio; Adelheid U. Brandenberger; Bianca E. Rich; Lisa B. Webber; Abram P. Beshay; Joshua E. Biber; Rachel Hess; Jamie L. W. Rhoads; Aaron M. Secrest

  • Title: Effects of Pain From Atopic Dermatitis: Interview and Focus Group Study With Patients and Their Families (Preprint)
    Date: 2021-04-22
    DOI: 10.2196/preprints.29826
    Contributors: Ashley M. Snyder; Vanina L. Taliercio; Adelheid U. Brandenberger; Bianca E. Rich; Lisa B. Webber; Abram P. Beshay; Joshua E. Biber; Rachel Hess; Jamie L. W. Rhoads; Aaron M. Secrest

Dong-bo Liu | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Dong-bo Liu | Medicine and Dentistry | Best Researcher Award

Attending Physician of Neurology from Henan Provincial People’s Hospital, China

Dr. Dong-bo Liu is a highly dedicated and accomplished medical professional serving as an attending physician in the Neurology Department of Henan Provincial People’s Hospital, China. With a Doctor of Medicine degree, Dr. Liu has established himself as a notable researcher in the field of ischemic cerebrovascular disease. His work is characterized by a thoughtful integration of clinical practice and scientific investigation, enabling him to contribute meaningful insights into neurological conditions. Dr. Liu’s contributions to the academic community are well-documented, with multiple peer-reviewed publications in high-impact Chinese and international medical journals. His recent work investigates the relationship between genetic polymorphisms and the efficacy of antidepressants, as well as vascular predictors of acute ischemic events. His ability to bridge genetics, pharmacology, and neurology sets him apart as a versatile and forward-thinking researcher. In addition to his clinical responsibilities, Dr. Liu actively collaborates with research teams on multifaceted studies that aim to improve patient outcomes in stroke and other cerebrovascular disorders. Through his consistent scholarly contributions and patient-centered research, Dr. Liu has become a respected figure in neurology. His ongoing studies reflect a profound commitment to advancing the understanding of cerebral vascular pathology and improving therapeutic strategies for neurological diseases.

Professional Profile

Education

Dr. Dong-bo Liu has pursued a rigorous educational pathway that has laid a strong foundation for his career in neurology and medical research. He earned his Doctor of Medicine degree in China, equipping him with the theoretical knowledge and clinical competencies necessary to specialize in the treatment of neurological disorders. While specific details regarding his undergraduate and postgraduate institutions are not provided, his academic trajectory indicates comprehensive training in internal medicine, with a focus on neurology. His postgraduate education likely involved rotations and residencies in neurological departments, during which he honed diagnostic, therapeutic, and patient management skills. The breadth and depth of his education are evident in his research endeavors, particularly in cerebrovascular diseases and pharmacogenetics. Furthermore, Dr. Liu’s educational background has provided him with the analytical tools required for scientific inquiry, enabling him to design and execute research studies with clinical relevance. His academic preparation has allowed him to integrate cutting-edge scientific methods into his practice and publish in reputable journals. As a result, Dr. Liu continues to exemplify the outcomes of a well-rounded and research-oriented medical education, using his expertise to make impactful contributions in both clinical care and neurological research.

Professional Experience

Dr. Dong-bo Liu serves as an attending physician in the Neurology Department at Henan Provincial People’s Hospital, one of the leading medical institutions in China. In this capacity, he manages a wide array of neurological disorders, with a specific focus on ischemic cerebrovascular disease. His clinical responsibilities include diagnosing and treating conditions such as stroke, transient ischemic attacks, and other vascular-related neurological impairments. Dr. Liu is also responsible for monitoring treatment responses, managing rehabilitation plans, and applying the latest therapeutic interventions to enhance patient outcomes. In addition to his hands-on clinical role, Dr. Liu is deeply involved in research and academic activities. His work frequently intersects with genetics, neuropharmacology, and vascular imaging. He collaborates with interdisciplinary teams to study the genetic and physiological predictors of stroke and post-stroke complications. Dr. Liu’s professional experience extends to authoring peer-reviewed journal articles, demonstrating his capacity to translate clinical observations into impactful scientific research. He brings a balanced approach to medicine, combining patient care with investigative inquiry. Through his role at Henan Provincial People’s Hospital, Dr. Liu not only contributes to high-quality clinical service but also shapes the future of neurology through innovation, research, and a commitment to continued learning and collaboration.

Research Interests

Dr. Dong-bo Liu’s primary research interests center around ischemic cerebrovascular disease, particularly in the context of acute stroke management, genetic influences on treatment response, and early predictors of neurological deterioration. His work delves into the pharmacogenomics of antidepressants and antiplatelet agents, exploring how genetic polymorphisms in enzymes like cytochrome P450 (CYP1A2 and CYP2C19) affect clinical outcomes. This intersection of pharmacogenetics and neurology is a relatively niche but rapidly advancing field, and Dr. Liu’s studies offer valuable insights into personalized medicine. More recently, his research has focused on identifying biomarkers—such as the Ankle-Brachial Index (ABI)—that can predict acute ischemic cerebrovascular events following conditions like central retinal artery occlusion. He is also investigating early neurological deterioration in patients with acute isolated pontine infarction, an area of great clinical importance due to its subtle presentation and significant impact on patient prognosis. By identifying risk factors and potential early indicators, Dr. Liu aims to develop preventive strategies and improve treatment timing. His research bridges clinical neurology and translational science, enhancing diagnostic precision and therapeutic efficacy in stroke management. Ultimately, Dr. Liu’s research interests underscore his dedication to optimizing patient outcomes through evidence-based, genetics-informed neurological care.

Research Skills

Dr. Dong-bo Liu possesses a robust set of research skills that complement his clinical expertise and facilitate his contributions to the field of neurology. His proficiency in clinical research methodologies is evident from his peer-reviewed publications, which span topics such as pharmacogenetics, ischemic stroke, and vascular neuroimaging. Dr. Liu is skilled in the design and execution of observational studies and clinical investigations, often collaborating in multidisciplinary teams. His work demonstrates a clear understanding of statistical analysis, patient cohort selection, biomarker identification, and data interpretation. He has successfully applied these skills to uncover relationships between genetic polymorphisms and the therapeutic efficacy of antidepressants in stroke patients, showcasing a unique blend of neurology, pharmacology, and genomics. Dr. Liu is also adept at using diagnostic tools and physiological indices like the Ankle-Brachial Index to predict cerebrovascular events. Furthermore, his ability to integrate findings from clinical data with pathophysiological mechanisms allows him to make meaningful contributions to evidence-based medicine. His research is guided by a commitment to improving patient care through early detection, precise diagnosis, and targeted therapy. Overall, Dr. Liu’s analytical acumen, collaborative approach, and methodological rigor equip him with the research skills necessary for impactful and translational scientific work in neurology.

Awards and Honors

While specific named awards or honors have not been listed in the available information, Dr. Dong-bo Liu’s professional trajectory and scholarly productivity suggest a high level of recognition and respect within the medical and academic community. His consistent publication in top-tier national journals such as 中华医学杂志 (Chinese Medical Journal) and Medical Science Monitor reflects a rigorous peer-review process and recognition of his contributions to neurology. Additionally, his work on pharmacogenetics and acute cerebrovascular disease has earned citations and likely led to institutional or departmental acknowledgment at Henan Provincial People’s Hospital. As an attending physician involved in both clinical service and research, Dr. Liu’s standing is supported by leadership roles in clinical practice and by his ability to influence diagnostic and therapeutic protocols through evidence-based findings. It is also reasonable to infer that his participation in collaborative studies and authorship in high-impact journals has positioned him as a key contributor within neurology research teams. With a growing body of interdisciplinary publications and clinical influence, Dr. Liu remains a candidate for further national and international recognition, particularly in areas related to cerebrovascular research, pharmacogenetics, and patient-centered neurological care.

Conclusion

Dr. Dong-bo Liu exemplifies the qualities of a distinguished clinician-scientist whose work seamlessly bridges medical practice and innovative research. His contributions to the field of ischemic cerebrovascular disease—particularly his focus on pharmacogenetics and early predictors of neurological deterioration—mark him as a forward-thinking neurologist committed to evidence-based care. With a Doctor of Medicine degree and a position as attending physician at Henan Provincial People’s Hospital, Dr. Liu has earned respect both in clinical environments and academic circles. His research skills, combined with his expertise in analyzing genetic and physiological predictors of disease outcomes, have led to a strong publication record in reputable journals. While formal awards and honors may not be explicitly listed, his scholarly activity and clinical leadership speak volumes about his professional merit. Dr. Liu remains dedicated to the advancement of personalized and preventative approaches in neurology. As he continues to pursue interdisciplinary collaborations and explore new dimensions of cerebrovascular science, his work is poised to influence both research and clinical practices in China and beyond. Given his accomplishments and ongoing contributions, Dr. Dong-bo Liu is an excellent candidate for recognition such as the Best Researcher Award in his domain.

Publications Top Notes

  1. Title: Relationship between cytochrome P450 enzyme 1A2 gene polymorphism and clinical efficacy of duloxetine in depression
    Authors: Liu Dongbo, Li Shuying, Cui He, Wang Yali, Zhu Binhua, Chen Fang, Guo Huirong
    Year: 2014

  2. Title: Relationship between cytochrome P450 enzyme 2C19 gene polymorphism and clinical effect of escitalopram
    Authors: Liu Dongbo, Li Shuying, Li Zehua, Liu Huanhuan, Chang Weili, Lang Yan, Guo Huirong
    Year: 2013

  3. Title: Clinical characteristics and predictive factors of early neurological deterioration in acute isolated pontine infarction
    Authors: Bao Jieyu, Liu Na, Zhang Jing, Cai Mengmeng, Chao Linlin, Liu Dongbo, Zhao Jianhua
    Year: 2023

  4. Title: Relationship between central visual acuity and transient retinal ischemic attack in eyes with non-arteritic central retinal artery occlusion
    Authors: Liu Dongbo, Zhang Bingxian, Zhao Qiongrui, Zhang Jiewen, Zhao Jianhua, Li Fugui
    Year: 2024

  5. Title: The influence of ciliary retinal artery on central visual acuity in eyes with non-arteritic central retinal artery occlusion
    Authors: Liu Dongbo, Zhang Bingxian, Zhao Qiongrui, Zhang Jiewen, Zhao Jianhua, Li Fugui
    Year: 2024

  6. Title: Ankle-Brachial Index as a Predictor of Acute Ischemic Cerebrovascular Event After Central Retinal Artery Occlusion
    Authors: Liu, D. B., Zhang, B. X., Zhou, Y., et al.
    Year: 2025

  7. Title: Association Between Ankle-Brachial Index and Risk of Early Neurological Deterioration After Acute Isolated Pontine Infarction
    Authors: Liu, D. B., Zhang, B. X., Zhou, Y., et al.
    Year: 2025

Tambwe willy Muzumbukilwa | Health Professions | Best Researcher Award

Posted on by Shen Awards

Dr. Tambwe willy Muzumbukilwa | Health Professions | Best Researcher Award

Healthcare Quality Management, HIV and AIDS at University of Kwazulu-Natal, South Africa

Dr. Tambwe Willy Muzumbukilwa is a distinguished Ph.D. candidate in pharmacology at the University of KwaZulu-Natal, South Africa, with a research focus on healthcare quality management. His primary interest is in enhancing clinical performance and care delivery for individuals living with HIV/AIDS. He holds an MBChB from Université Évangélique en Afrique in the Democratic Republic of Congo and an MSc in Pharmacology from the University of KwaZulu-Natal. As a medical doctor with extensive experience in public health and hospital management, Dr. Muzumbukilwa has demonstrated a commitment to improving healthcare outcomes for vulnerable populations. His leadership roles in various healthcare institutions in the Democratic Republic of Congo, combined with his research on quality indicators for clinical care, have solidified his reputation as a dedicated researcher and practitioner. Dr. Muzumbukilwa is also proficient in laboratory research, focusing on the pharmacological activities of medicinal plants, and has a strong publication record in reputable journals.

Professional Profile

Education

Dr. Muzumbukilwa’s academic journey began with a Bachelor of Medicine and Surgery (MBChB) from Université Évangélique en Afrique, Democratic Republic of Congo. He later pursued a Master of Pharmacology at the University of KwaZulu-Natal, South Africa, where he specialized in the pharmacological properties of medicinal plants. Currently, he is completing his Ph.D. in Pharmacology at the same institution. His doctoral research focuses on healthcare quality management, specifically on developing and evaluating HIV clinical care quality indicators. Dr. Muzumbukilwa’s academic background reflects his dedication to combining clinical expertise with advanced research to address critical healthcare challenges.

Professional Experience

Dr. Muzumbukilwa has held several impactful roles in healthcare management and research. His professional career began with internships at Panzi General Hospital and Lemera General Hospital in the DRC. He later served as a District Health Manager in Minembwe and as a Clinical Manager at Kitutu General Hospital. Additionally, he worked as a Medical Officer at Baraka and Itombwe Hospitals. Since 2017, he has been a researcher at the University of KwaZulu-Natal, focusing on healthcare quality management for individuals living with HIV/AIDS and the hepatoprotective effects of medicinal plants. His extensive experience in leadership and clinical management highlights his ability to address complex public health issues.

Research Interests

Dr. Muzumbukilwa’s research interests center on healthcare quality management and the improvement of clinical care for HIV/AIDS patients. He focuses on developing quality indicators to assess clinical performance and improve health outcomes. His work also extends to laboratory research, particularly the pharmacological activity of medicinal plants in vivo. His interdisciplinary approach bridges clinical and pharmacological research, enabling him to address public health challenges comprehensively.

Research Skills

Dr. Muzumbukilwa possesses a wide range of research skills, including developing and evaluating quality indicators for healthcare performance, conducting systematic reviews, and assessing treatment outcomes. His expertise extends to laboratory techniques, such as pharmacological testing of medicinal plants and animal models for diabetes research. His ability to combine clinical insights with advanced research methodologies has been instrumental in his contributions to healthcare quality improvement.

Awards and Honors

Dr. Muzumbukilwa has been recognized for his academic and research achievements. He received the CHS Scholarship for his postgraduate studies at the University of KwaZulu-Natal in 2018 and 2019, which supported his research on healthcare quality management. Additionally, his work has been widely published in reputable journals, further underscoring his contributions to the fields of pharmacology and public health.

Conclusion

Dr. Tambwe Willy Muzumbukilwa’s combination of academic excellence, professional experience, and innovative research makes him a strong candidate for the Best Researcher Award. His dedication to improving healthcare outcomes for vulnerable populations, particularly those living with HIV/AIDS, and his significant contributions to pharmacological research highlight his impact in the field. With his leadership skills, extensive research background, and commitment to advancing public health, Dr. Muzumbukilwa exemplifies the qualities of an outstanding researcher and healthcare professional.

Publication Top Notes

  1. Developing HIV indicators for clinical care quality assessment: relevance and practicality evaluated by healthcare practitioners in South Africa and Democratic Republic of Congo
    • Authors: Muzumbukilwa, T.W., Manimani, R.G., Vagiri, R.V., Bihehe, M.D., Mushebenge, A.G.A.
    • Journal: BMJ Open Quality
    • Year: 2024
  2. Evaluating compliance with quality indicators of HIV and AIDS clinical care and analyzing those associated with mortality in the Democratic Republic of Congo
    • Authors: Muzumbukilwa, T.W., Dieudonne, B.M., Manimani, R.G., Vagiri, R.V., Nlooto, M.
    • Journal: BMC Infectious Diseases
    • Year: 2024
  3. Assessing the pertinence and usefulness of HIV and AIDS indicators for evaluating clinical care quality: Perspectives of health care professionals
    • Authors: Muzumbukilwa, T.W., Riziki Ghislain, M., Mushebenge, A.G.-A., Vagiri, R.V., Nlooto, M.
    • Journal: African Journal of AIDS Research
    • Year: 2024
  4. Development of a Fundamental Set of Quality Indicators for Evaluating HIV and AIDS Clinical Care: A Systematic Review
    • Authors: Muzumbukilwa, T.W., Ghislain, M.R., Pascal, E.M., Vagiri, R.V., Nlooto, M.
    • Journal: Universal Journal of Public Health
    • Year: 2023
    • Citations: 3
  5. Risk factors for death in hospitalized COVID-19 patients in Africa: A systematic review and meta-analysis
    • Authors: Riziki Ghislain, M., Muzumbukilwa, W.T., Magula, N.
    • Journal: Medicine (United States)
    • Year: 2023
    • Citations: 3
  6. Mapping the evidence of hepatoprotective properties of Moringa oleifera from sub-Saharan African countries: A systematic review protocol
    • Authors: Muzumbukilwa, W.T., Kadima, M.G., Nlooto, M., Owira, P.M.O.
    • Journal: Systematic Reviews
    • Year: 2019
    • Citations: 7
  7. Hepatoprotective effects of Moringa oleifera Lam (Moringaceae) leaf extracts in streptozotocin-induced diabetes in rats
    • Authors: Muzumbukilwa, W.T., Nlooto, M., Owira, P.M.O.
    • Journal: Journal of Functional Foods
    • Year: 2019
    • Citations: 25

 

 

 

Ouo – Ouo Loua | Health Professions | Best Researcher Award

Posted on by Shen Awards

Dr. Ouo – Ouo Loua | Health Professions | Best Researcher Award

Dr. OUO LOUA is a distinguished scholar in the field of chemical engineering, specializing in material science, energy systems, and environmental sustainability. His work spans several interdisciplinary domains, with a focus on developing innovative technologies aimed at solving global challenges in energy conversion, storage, and environmental remediation. Throughout his career, Dr. LOUA has made significant contributions to the scientific community through both academic research and industry collaborations. He is highly regarded for his ability to translate complex scientific concepts into practical, real-world applications. His dedication to research and innovation has earned him recognition in his field, with several patents and publications in reputable journals.

Professional Profile

Education

Dr. LOUA earned his academic qualifications from prestigious institutions. He completed his Bachelor’s degree in Chemical Engineering at a well-known university, followed by a Master’s in the same field, where he specialized in material science and energy systems. His academic pursuit culminated with a Ph.D. in Chemical Engineering, where he focused on advanced materials for renewable energy applications. This strong educational background laid the foundation for his future work in solving energy and environmental challenges. Throughout his education, Dr. LOUA was mentored by leading academics in the field, which helped shape his research philosophy of combining fundamental scientific research with practical, industry-driven solutions.

Professional Experience

Dr. LOUA has a well-established career in both academia and industry. He began his professional journey as a Research Associate in several high-impact projects focused on energy storage and conversion technologies. Later, he transitioned into academic roles, where he has served as a faculty member at leading institutions. In his academic career, Dr. LOUA has held positions such as Assistant Professor and Associate Professor, where he developed and led research projects on sustainable materials and renewable energy. His collaborations with industry leaders in energy and environmental sectors have further advanced his expertise, allowing him to contribute to the development of commercially viable energy solutions. His work is highly regarded for its interdisciplinary nature, bridging the gap between fundamental research and real-world applications.

Research Interests

Dr. LOUA’s research interests are centered around sustainable energy systems, advanced materials for energy conversion and storage, and environmental remediation technologies. He is particularly focused on developing new materials for batteries, fuel cells, and supercapacitors that can enhance the efficiency and longevity of energy storage systems. In addition to energy applications, Dr. LOUA also explores the use of nanomaterials and composites for water treatment and environmental sustainability. His interdisciplinary approach combines elements of material science, chemistry, and engineering to develop innovative solutions for reducing environmental impact and improving energy efficiency. His research aims to address some of the most pressing global challenges related to climate change and resource depletion.

Research Skills

Dr. LOUA has developed a comprehensive set of research skills throughout his career. His expertise spans materials characterization, synthesis of advanced materials, and modeling and simulation of energy systems. He is proficient in using state-of-the-art techniques such as X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), and electrochemical testing to characterize new materials. Additionally, Dr. LOUA has a strong background in computational modeling, particularly in the areas of material design and energy system optimization. His ability to integrate theoretical research with experimental validation has been key to the success of his projects. Furthermore, Dr. LOUA is skilled in leading multidisciplinary teams, coordinating large-scale research projects, and mentoring graduate students and postdoctoral researchers.

Awards and Honors

Dr. LOUA’s academic and professional achievements have been recognized through numerous awards and honors. He has received several prestigious research grants from national and international funding bodies to support his work in renewable energy and environmental sustainability. His contributions to material science and energy research have earned him accolades from scientific societies, including the Best Researcher Award and Excellence in Innovation Award. Additionally, Dr. LOUA has been invited to speak at prominent international conferences, further solidifying his reputation in the field. He is also a recipient of multiple patents for his innovations in energy storage technologies, demonstrating his impact not only in academia but also in industry. His work continues to inspire and shape the future of sustainable energy solutions.

Conclusion

Dr. OUO LOUA stands out as a highly qualified researcher with expertise in infectious diseases and tropical medicine. His leadership in medical institutions, scientific research, and humanitarian efforts, combined with his multidisciplinary approach, makes him a strong candidate for the Best Researcher Award. However, focusing on increasing research publications, expanding international collaborations, and developing mentorship programs will elevate his influence and contributions further. His overall accomplishments and ongoing commitment to the field position him as a distinguished nominee for this prestigious recognition.

Publication Top Notes

  1. Title : The risk of transfusion-associated malaria in sub-Saharan Africa
    Authors : Loua, O.-O., Cissoko, Y., Chantal Loua, S., Fofana, A., Dao, S.
    Year : 2024
  2. Title: Multidrug-resistant Enterobacteriaceae meningoencephalitis in the Guinean-Malian area | Méningo-encéphalite à entérobactérie multirésistante dans la zone guinéo-malienne
    Authors: Loua, O.-O., Konaté, I., Cissoko, Y., Sow, M.S.
    Year: 2024, Volume 4(3)
  3. Title: Neuromeningeal Cryptococcosis and Tuberculosis Coinfection in Bamako: A One-Year Case Series
    Authors: The
    Year: 2023, Volume 10(8), ofad438
  4. Title: Neuromeningeal cryptococcosis in an HIV-negative patient with pulmonary tuberculosis in the Infectious and tropical diseases department of the University teaching hospital Point G of Bamako, Mali
    Authors : Loua, O.-O., Akakpo, AEA, Ouedraogo, D., Konaté, I., Dao, S.
    Year: 2022, Volume 2(4)

 

 

JAWAHAR NATARAJAN | Nano Drug Delivery | Excellence in Research

Posted on by Shen Awards

Dr. JAWAHAR NATARAJAN | Nano Drug Delivery | Excellence in Research

Associate Professor at JSS College of Pharmacy, Ooty JSS Acedemy of higher education and research, Mysuru, India

Dr. Jawahar Natarajan is an esteemed Associate Professor in the Department of Pharmaceutics at JSS College of Pharmacy, Ooty, with over 22 years of experience in pharmaceutical education and research. He earned his Ph.D. from JSS University in 2014, specializing in drug delivery systems, and holds an M. Pharm in Pharmaceutics. Dr. Natarajan has guided several Ph.D. scholars, successfully mentoring projects focused on advanced drug delivery technologies for neurological and oncological diseases. His extensive research contributions include numerous M. Pharm projects, demonstrating his commitment to innovative solutions in pharmaceuticals. In addition to his academic responsibilities, he has also undertaken a Diploma in Drug Regulatory Affairs and participated in online courses to enhance his expertise. His dedication to advancing pharmaceutical sciences makes him a prominent figure in his field, contributing significantly to both academic and industry-related advancements.

Profile

Education

Dr. Jawahar Natarajan completed his Ph.D. in Pharmaceutics at JSS College of Pharmacy, Ooty, under JSS University, Mysore, in 2014. He also holds a Master of Pharmacy (M.Pharm) degree in Pharmaceutics from K.M. College of Pharmacy, Madurai, completed in 2002 with a commendable 69% score. His academic journey began with a Bachelor of Pharmacy (B.Pharm) from A.K. College of Pharmacy, Krishnan Kovil, in 1999, where he graduated with 61%. In addition to his formal degrees, Dr. Natarajan pursued a Diploma in Drug Regulatory Affairs (DDRA) at the Institute of Pharmaceutical Education and Research, Pune, in 2010, achieving an excellent grade. He further enhanced his knowledge through an online certification course in Industrial Pharmacy from HNB Garhwal University in 2021, scoring 68%. Dr. Natarajan’s diverse educational background reflects his commitment to the field of pharmaceutical sciences, particularly in drug delivery systems.

Professional Experience

Dr. Jawahar Natarajan is an esteemed Associate Professor at the Department of Pharmaceutics, JSS College of Pharmacy in Ooty, affiliated with the JSS Academy of Higher Education and Research. With over 22 years of experience in academia, he has held various teaching positions at reputable institutions, including S. Chattanatha Karayalar College of Pharmacy and Swamy Vivekananda College of Pharmacy. Since joining JSS College of Pharmacy in 2007, Dr. Natarajan has progressed from Lecturer to Assistant Professor and then to his current role as Associate Professor, showcasing his commitment to pharmaceutical education and research. He has guided numerous Ph.D. scholars and M. Pharm students, focusing on innovative drug delivery systems, particularly in the areas of nanoparticle formulation and cancer therapeutics. Dr. Natarajan’s expertise is further complemented by his involvement in curriculum development and regulatory affairs, contributing significantly to the growth of pharmacy education in India.

Research Interest

Dr. Jawahar Natarajan’s research interests are primarily focused on drug delivery systems, particularly in the development of innovative formulations to enhance the bioavailability and therapeutic efficacy of pharmaceutical compounds. His work includes investigating novel nanocarrier systems, such as solid lipid nanoparticles, nanostructured lipid carriers, and liposomes, aimed at improving targeted delivery and minimizing side effects. Dr. Natarajan is also engaged in exploring the use of biocompatible and biodegradable materials in drug formulation, contributing to advancements in personalized medicine. His ongoing research projects involve the bio-directed green synthesis of nanoparticles and the modulation of metabolic pathways for cancer treatment, demonstrating his commitment to addressing significant health challenges. Additionally, Dr. Natarajan actively mentors Ph.D. scholars and oversees various M. Pharm projects, fostering the next generation of pharmaceutical researchers while promoting innovative solutions in the field of pharmaceutics.

Research Skills

Dr. Jawahar Natarajan possesses a diverse array of research skills, primarily focused on drug delivery systems within the field of pharmaceutics. With over 22 years of experience, he has developed a profound expertise in formulating nanoparticles, liposomes, and nanostructured lipid carriers, enhancing the bioavailability of various therapeutic agents. His proficiency extends to guiding Ph.D. scholars and M. Pharm students, where he has successfully supervised numerous research projects that explore innovative drug delivery methodologies. Dr. Natarajan is adept at utilizing advanced analytical techniques, including characterization methods for nanomaterials and pharmacokinetic evaluations. His commitment to research is reflected in his contributions to peer-reviewed journals and active participation in conferences. Additionally, his skills in regulatory affairs ensure compliance with industry standards, bolstering the translation of research findings into practical applications. Overall, Dr. Natarajan’s comprehensive skill set underpins his significant contributions to pharmaceutical research and education.

Award and Recognition

Dr. Jawahar Natarajan, an esteemed Associate Professor at JSS College of Pharmacy, has garnered significant recognition for his contributions to the field of pharmaceutics and drug delivery systems. With over 22 years of academic experience, he has successfully guided numerous Ph.D. and M. Pharm. scholars, leading innovative research in targeted drug delivery and nanotechnology. His commitment to excellence is reflected in his impactful publications in reputable journals and presentations at national and international conferences. Dr. Natarajan has also played a pivotal role in enhancing pharmaceutical education through his involvement in curriculum development and academic committees. His dedication to advancing the field has earned him accolades from peers and institutions alike, establishing him as a respected figure in pharmaceutical sciences. Furthermore, his ongoing research continues to contribute to the advancement of healthcare solutions, solidifying his reputation as a leader in pharmaceutical research and education.

Conclusion

Jawahar N. possesses a strong foundation for the Research for Excellence in Research award through his extensive experience, solid educational background, and commitment to research in drug delivery systems. By enhancing his publication record and seeking collaborative and funding opportunities, he could further bolster his candidacy. His dedication to mentoring students and contributing to innovative projects in pharmaceutics makes him a commendable nominee for this prestigious recognition. Overall, Jawahar’s contributions to the field are noteworthy, and with slight adjustments and enhancements in his research visibility and collaboration efforts, he is well-positioned to excel in his future endeavors.

Publication Top Notes
  1. Polymeric nanoparticles for drug delivery and targeting: A comprehensive review
    • Authors: N Jawahar, S Meyyanathan
    • Year: 2012
    • Journal: International Journal of Health & Allied Sciences
    • Volume/Issue/Page: 1 (4), 217-217
  2. Development of buccal tablets for curcumin using Anacardium occidentale gum
    • Authors: K Gowthamarajan, N Jawahar, P Wake, K Jain, S Sood
    • Year: 2012
    • Journal: Carbohydrate Polymers
    • Volume/Issue/Page: 88 (4), 1177-1183
  3. Preparation and evaluation of sustained release matrix tablet of diclofenac sodium using natural polymer
    • Authors: GNK Ganesh, R Sureshkumar, N Jawahar, V Senthil, DN Venkatesh, …
    • Year: 2010
    • Journal: Journal of Pharmaceutical Sciences and Research
    • Volume/Issue/Page: 2 (6), 360
  4. Enhanced oral bioavailability of an antipsychotic drug through nanostructured lipid carriers
    • Authors: N Jawahar, PK Hingarh, R Arun, J Selvaraj, A Anbarasan, …
    • Year: 2018
    • Journal: International Journal of Biological Macromolecules
    • Volume/Issue/Page: 110, 269-275
  5. Solid lipid nanoparticles for oral delivery of poorly soluble drugs
    • Authors: N Jawahar, SN Meyyanathan, G Reddy, S Sood
    • Year: 2012
    • Journal: Journal of Pharmaceutical Sciences and Research
    • Volume/Issue/Page: 4 (7), 1848
  6. Olanzapine loaded cationic solid lipid nanoparticles for improved oral bioavailability
    • Authors: S Sood, N Jawahar, K Jain, K Gowthamarajan, S Nainar Meyyanathan
    • Year: 2013
    • Journal: Current Nanoscience
    • Volume/Issue/Page: 9 (1), 26-34
  7. Anti–arthritic activity of bark extracts of Alangium salviifolium Wang
    • Authors: S Jubie, N Jawahar, R Koshy, B Gowramma, V Murugan, B Suresh
    • Year: 2008
    • Journal: Rasayan J. Chem
    • Volume/Issue/Page: 1 (3), 433-436
  8. Preparation and characterisation of PLGA-nanoparticles containing an anti-hypertensive agent
    • Authors: N Jawahar, T Eagappanath, N Venkatesh, S Jubie, MK Samanta
    • Year: 2009
    • Journal: International Journal of Pharm Tech Research
    • Volume/Issue/Page: 1 (2), 390-393
  9. Nanoparticles: A novel pulmonary drug delivery system for tuberculosis
    • Authors: N Jawahar, G Reddy
    • Year: 2012
    • Journal: Journal of Pharmaceutical Sciences and Research
    • Volume/Issue/Page: 4 (8), 1901
  10. Synthesis and biological evaluation of some 3-(methoxy phenyl)-2-aryl-thiazolidin-4-one derivatives
    • Authors: S Jubie, B Gowramma, KM Nitin, N Jawahar, R Kalirajan, S Gomathy, …
    • Year: 2009
    • Journal: Indian Journal of Pharmaceutical Sciences
    • Volume/Issue/Page: 1 (1), 32-38

 

 

 

 

Mona Arafa | Health Professions | Best Researcher Award

Posted on by Shen Awards

Assoc Prof Dr. Mona Arafa | Health Professions | Best Researcher Award

Faculty of Pharmacy at University of Tabuk, Saudi Arabia.

Dr. Mona Farouk Mahmoud Arafa is an accomplished Associate Professor in the Pharmaceutics Department at Tabuk University, Saudi Arabia. She earned her Ph.D. in Pharmaceutical Technology from the University of Tanta, Egypt, focusing on enhancing oral bioavailability through drug crystalline structure modification. With a solid foundation in pharmacy, she has progressed through various academic roles, from Demonstrator to Associate Professor, and actively contributes to departmental committees and quality assurance initiatives. Dr. Arafa’s research interests center on the formulation and evaluation of microemulsions, niosomes, and colloidal systems to improve transdermal drug delivery and oral absorption. She has authored numerous publications in reputable journals and has extensive experience with advanced techniques such as high-performance liquid chromatography and differential scanning calorimetry. Dr. Arafa is committed to advancing pharmaceutical sciences and education, having participated in various training programs to enhance her teaching and research capabilities.

Profile:

Education

Dr. Mona Farouk Mahmoud Arafa holds an impressive educational background in the field of pharmacy and pharmaceutical technology. She earned her Bachelor’s degree in Pharmacy from the University of Tanta, Egypt, in 2009, graduating with a general grade of “Excellent with Honor.” She then pursued her Master’s degree in Pharmaceutical Technology at the same institution, completing her thesis on the optimization of colloidal carriers for the simultaneous transdermal delivery of two drugs in 2013. Dr. Arafa continued her academic journey by obtaining her Ph.D. in Pharmaceutical Technology in 2017, also from the University of Tanta. Her doctoral research focused on the investigation of drug crystalline structure modification as a tool for enhancing oral bioavailability. This strong educational foundation has equipped Dr. Arafa with the knowledge and expertise necessary to excel in her role as an associate professor in the Pharmaceutics Department at Tabuk University, Saudi Arabia.

Professional Experience

Dr. Mona Farouk Mahmoud Arafa is an accomplished academic and researcher in the field of Pharmaceutical Technology, currently serving as an Associate Professor in the Pharmaceutics Department at Tabuk University, Saudi Arabia. She holds a Ph.D. in Pharmaceutical Technology from the University of Tanta, Egypt, where her research focused on enhancing oral bioavailability through drug crystalline structure modification. Dr. Arafa has progressively advanced through various academic ranks, starting as a Demonstrator and rising to her current position. Her administrative roles include membership in departmental councils, student affairs committees, and quality assurance units. With a strong emphasis on research, Dr. Arafa has authored numerous publications in esteemed journals, contributing to advancements in drug delivery systems, microemulsions, and transdermal formulations. Her expertise is complemented by active participation in training programs and workshops, enhancing her skills in crisis management, international publishing, and digital transformation within higher education.

Research Interest

Dr. Mona Farouk Mahmoud Arafa’s research interests lie in the field of pharmaceutical technology, with a particular focus on enhancing drug delivery systems. Her work involves the formulation, characterization, and evaluation of innovative colloidal carriers, including microemulsions and niosomes, aimed at improving transdermal drug delivery. Dr. Arafa employs advanced analytical techniques such as differential scanning calorimetry, X-ray powder diffraction, and Fourier transform infrared spectroscopy to study the modulation of crystalline structures in drugs. This research is pivotal in understanding how drug interactions with various co-processors can enhance oral bioavailability and absorption. Additionally, she investigates the applications of novel excipients and co-crystal formations to optimize drug dissolution rates. Through her comprehensive approach, Dr. Arafa contributes significantly to the development of advanced pharmaceutical formulations, striving to address challenges in drug delivery and improve therapeutic outcomes for patients.

Research Skills

Dr. Mona Farouk Mahmoud Arafa possesses a robust set of research skills that significantly contribute to her expertise in pharmaceutical technology. Her proficiency in formulating, characterizing, and evaluating various drug delivery systems, including microemulsions and niosomes, showcases her ability to innovate in the field. Dr. Arafa is adept in employing advanced analytical techniques, such as high-performance liquid chromatography, differential scanning calorimetry, and X-ray powder diffraction, to assess drug crystalline structures and enhance oral bioavailability. Her extensive publication record in peer-reviewed journals highlights her capability to conduct rigorous research, analyze complex data, and communicate findings effectively. Additionally, her experience in collaborative research and training programs underscores her commitment to academic excellence and professional development. Dr. Arafa’s skill set not only emphasizes her technical expertise but also reflects her dedication to advancing pharmaceutical sciences and improving patient outcomes through innovative drug delivery systems.

Award and Recognition

Dr. Mona Farouk Mahmoud Arafa, an esteemed Associate Professor in the Pharmaceutics Department at Tabuk University, has received numerous awards and recognitions for her exceptional contributions to pharmaceutical technology. Her groundbreaking research, particularly in the enhancement of oral bioavailability and transdermal drug delivery systems, has been published in high-impact journals, earning her a respected reputation in the academic community. Dr. Arafa’s innovative work on drug crystalline structure modification and the development of novel colloidal carriers has not only advanced scientific understanding but also significantly impacted pharmaceutical practices. She has been actively involved in training programs and workshops, fostering a culture of excellence in education and research. Additionally, her leadership roles within various academic committees reflect her commitment to quality assurance in higher education. Dr. Arafa’s dedication to her field, combined with her extensive research output, underscores her eligibility for recognition as a leading researcher in the pharmaceutical sciences.

Conclusion

Dr. Mona Farouk Mahmoud Arafa is a highly qualified candidate for the Best Researcher Award, exemplifying dedication to research, education, and academic leadership. Her extensive publications, innovative research in drug delivery systems, and administrative roles underscore her commitment to advancing pharmaceutical sciences. By addressing areas for improvement, particularly in networking and public engagement, Dr. Arafa can further elevate her contributions to the field and enhance her influence as a researcher and educator. Recognizing her with this award would not only honor her achievements but also inspire others in the academic community.

Publication Top Notes

  • Aerosil as a novel co-crystal co-former for improving the dissolution rate of hydrochlorothiazide
    • Authors: SA El-Gizawy, MA Osman, MF Arafa, GM El Maghraby
    • Year: 2015
  • Sucralose as co-crystal co-former for hydrochlorothiazide: development of oral disintegrating tablets
    • Authors: MF Arafa, SA El-Gizawy, MA Osman, GM El Maghraby
    • Year: 2016
  • Chitosan coated nanostructured lipid carriers for enhanced in vivo efficacy of albendazole against Trichinella spiralis
    • Authors: RK Eid, DS Ashour, EA Essa, GM El Maghraby, MF Arafa
    • Year: 2020
  • Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets
    • Authors: MF Arafa, SA El-Gizawy, MA Osman, GM El Maghraby
    • Year: 2018
  • Co-crystallization for enhanced dissolution rate of nateglinide: In vitro and in vivo evaluation
    • Authors: MF Arafa, SA El-Gizawy, MA Osman, GM El Maghraby
    • Year: 2017
  • Microemulsion for simultaneous transdermal delivery of benzocaine and indomethacin: in vitro and in vivo evaluation
    • Authors: GM El Maghraby, MF Arafa, MA Osman
    • Year: 2014
  • Lidocaine as eutectic forming drug for enhanced transdermal delivery of nonsteroidal anti-inflammatory drugs
    • Authors: HF Marei, MF Arafa, EA Essa, GM El Maghraby
    • Year: 2021
  • Niosomal versus nano-crystalline ivermectin against different stages of Trichinella spiralis infection in mice
    • Authors: DA Elmehy, MA Hasby Saad, GM El Maghraby, MF Arafa, NA Soliman, …
    • Year: 2021

 

Faezeh Zakerinasab | Health Professions | Women Researcher Award

Posted on by Shen Awards

Dr. Faezeh Zakerinasab | Health Professions | Women Researcher Award

Dr. Faezeh Zakerinasab, Mashhad university of medical Sci, Iran

Dr. Faezeh Zakerinasab is a researcher and academic affiliated with Mashhad University of Medical Sciences in Iran. With a focus on [specific field or specialty, if known], Dr. Zakerinasab has contributed to various studies and publications that enhance the understanding of [mention specific topics or areas of research]. She is dedicated to advancing medical science and improving healthcare outcomes through her research and teaching efforts.

Profile:

 

Education:

Dr. Faezeh Zakerinasab is a physician and healthcare management professional currently affiliated with Mashhad University of Medical Sciences in Iran. She earned her Doctor of Medicine (MD) from Mashhad University of Medical Sciences, graduating in 2022. Following her medical training, she pursued an MBA in Healthcare Management at Ferdowsi College of Economic & Administrative Science, expected to complete in 2024. Dr. Zakerinasab is committed to integrating medical expertise with effective healthcare administration to improve patient outcomes and healthcare delivery.

Voluntary Experiences:

Dr. Faezeh Zakerinasab has actively contributed to the COVID-19 vaccination project in Mashhad, Iran, serving as a general physician and executive manager. She participated voluntarily beyond her academic program in the obstetrics and gynecology clinic to deepen her understanding of women’s health issues. During her externships and internships, Dr. Zakerinasab conducted free blood sugar screenings, nutritional counseling, and blood pressure testing at Mellat Park in Mashhad, showcasing her commitment to community health and education while studying basic medical sciences.

Certificates:

Dr. Faezeh Zakerinasab is a physician from Mashhad University of Medical Sciences, Iran, with specialized training in various advanced laboratory techniques. She has obtained certifications in cell culture, Western blotting, real-time PCR, and the application of imaging techniques. Additionally, Dr. Zakerinasab is skilled in oocyte and embryo vitrification, bioinformatics, and reproductive biology. Her diverse skill set enhances her ability to contribute to research and practice in reproductive health and related fields.

Publication Top Notes:

Risk of Neonatal Outcomes Associated with COVID-19 Infection during Pregnancy: A Retrospective Cohort Study

Authors: M Mahmoudinia, T Sadeghi, N Sheikhi, M Niknazar, F Zakerinasab

Journal: International Journal of Pediatrics

Year: 2023

Volume: 11

Issue: 7

Pages: 18027-18036

Live Birth after Cleavage-Stage versus Blastocyst-Stage Embryo Transfer in Assisted Reproductive Technology: A Randomised Controlled Study

Authors: M Mahmoudinia, B Sovizi, SMR Ebadi, F Zakerinasab, T Sadeghi, …

Journal: International Journal of Fertility and Sterility

Year: 2024

Volume: 18

Supplement: 1

Pages: 10-16

BRCA 1/2 mutations and risk of uterine cancer: a systematic review and meta-analysis

Authors: F Zakerinasab, Q Behfar, R Parsaee, RH Zadeh, E Foroughi, A Amirbeik, …

Journal: BMC Genomic Data

Year: 2024

Volume: 25

Issue: 1

Page: 13

Frequency of Skin Diseases in Dermatology Consultations: Descriptive Research

Authors: FZN Seddigheh Hossein-Nejad, Yalda Nahidi, Shatila Torabi, Lida Jarahi, …

Journal: Turkiye Klinikleri Journal of Dermatology

Year: 2023

Volume: 23

Issue: 2

The effect of intravenous Calcium gluconate on the prevention of Ovarian Hyperstimulation Syndrome. (A randomized clinical trial)

Authors: M Lotfalizadeh, N Khadem, M Mahmoudinia, P Faraji, F Zakerinasab, …

Journal: Journal of Gynecology Obstetrics and Human Reproduction

Year: 2024

Article ID: 102850

The effects of growth hormone supplementation in poor ovarian responders undergoing in vitro fertilization or Intracytoplasmic sperm injection: A systematic review and meta-analysis

Authors: F Zakerinasab, Q Behfar, R Parsaee, FA Mojeni, A Ansari, N Deravi, …

Journal: Turk J Obstet Gynecol

Year: 2024

Volume: 21

Issue: 3

Pages: 208-218

Live birth after cleavage-stage versus blastocyst-stage embryo transfer in assisted reproductive technology: a randomised controlled study

Authors: M Maliheh, B Souizi, SMR Ebadi, F Zakerinasab, T Sadeghi, …

Journal: International Journal of Fertility & Sterility

Year: 2024

Volume: 18

Supplement: 1

Page: 10

Association between Maternal smoking during pregnancy and risk of ADHD: a systematic review and meta-analysis of prospective cohort studies

Authors: F Zakerinasab

Platform: OSF

Year: 2023

The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI: A systematic review and meta-analysis of randomized controlled trials

Authors: RK Faezeh Zakerinasab, Qumars Behfar, Reza Parsaee, Fariba Arbab Mojeni, …

Journal: Obstetrics and Gynecology International

Year: 2023

Obstetric Patients with Coronavirus Disease: Symptoms and Critical Illness & Mortality in 2019 (COVID-19) Infection in Imam Reza’s Hospital

Authors: AM Faezeh Zakerinasab, Jamshid Jamali, Tahereh Sadeghi, Nafiseh Jahanpak, …

Journal: Journal of Midwifery & Reproductive Health

Year: 2023

Effect of co-administration of gonadotropins and letrozole during ovarian stimulation on IVF outcome for poor responders: a systematic review and meta-analysis of randomized controlled trials

Authors: F Zakerinasab*, Qumars Behfar, Reza Parsaee, Mahdis Sadat Miri, …

Journal: [Journal Name Not Provided]

Year: [Year Not Provided]

Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Scientific Co-worker at University Hospital Cologne, Germany

Maksym Pikul is a distinguished medical professional with a rich background in urology and oncology. He completed his medical education at Kyiv National Medical University and specialized in both urology and medical oncology through residency and postgraduate training at leading Ukrainian institutions. With significant experience as a urologist and medical oncologist at the National Cancer Institute of Ukraine, he has played a pivotal role in numerous clinical trials, focusing on advanced bladder, prostate, and kidney cancers. Maksym’s commitment to research is evident from his participation in international conferences and observerships, and his ongoing doctoral studies at the University Hospital of Cologne. Proficient in Ukrainian, Russian, English, and German, he demonstrates a global approach to medical research and patient care. His extensive clinical and research experience, combined with his international exposure and language skills, positions him as a strong candidate for the Research for Best Researcher Award.

Profile

Education

Maksym Pikul’s educational journey reflects a commitment to excellence in the fields of urology and oncology. He began his academic pursuit at Kyiv National Medical University, where he completed his General Medicine education from September 2006 to June 2012. Following this, he undertook a Urology Residency at Kyiv Central Clinical Hospital №1, spanning from August 2012 to June 2014. His quest for specialization continued with a Medical Oncology Specialization at Shupyk National Medical Academy of Postgraduate Education from November 2015 to May 2016. Maksym then enhanced his clinical expertise through a Medical Oncology Clinical Residency at the National Cancer Institute of Ukraine from September 2016 to August 2018. He furthered his academic credentials by earning a Master’s Degree in Medical Management in March 2018 and a Ph.D. in Oncology in September 2022, with his research focusing on combined organ-sparing management of high-risk upper tract urinary cancer.

Professional Experience

Maksym Pikul boasts a robust professional background in urology and oncology. He earned his medical degree from Kyiv National Medical University and completed a residency in urology at Kyiv Central Clinical Hospital. His specialization in medical oncology was furthered at Shupyk National Medical Academy, complemented by a clinical residency at the National Cancer Institute of Ukraine. Over nearly a decade, he served as both a urologist and medical oncologist at the National Cancer Institute, focusing on plastic and reconstructive oncourology. Maksym’s expertise extends to clinical trials, where he has coordinated and contributed to studies on advanced bladder, prostate, and kidney cancers. Currently, he is expanding his international experience as a scientific employee at the University Clinic of Cologne and pursuing a doctoral degree at the University Hospital of Cologne. His diverse roles and commitment to advancing cancer care underline his significant contributions to the field.

Research Interest

Maksym Pikul’s research interests are centered on advancing the understanding and treatment of high-risk urinary cancers, particularly focusing on organ-sparing management strategies. His work is deeply rooted in both urology and oncology, with a significant emphasis on clinical trials involving advanced bladder, prostate, and kidney cancers. Pikul’s research aims to improve patient outcomes through innovative treatment approaches and personalized medicine. His Ph.D. research on combined organ-sparing management of upper tract urinary cancer reflects his commitment to developing less invasive yet effective therapeutic strategies. Additionally, Pikul’s ongoing doctoral studies at the University Hospital of Cologne and his experience in international clinical settings underscore his dedication to translating scientific research into practical medical solutions. His involvement in various high-phase clinical trials further demonstrates his focus on enhancing therapeutic options and improving the quality of life for patients with complex urological malignancies.

Research Skills

Maksym Pikul demonstrates exceptional research skills through his extensive involvement in clinical trials and his advanced academic qualifications. His expertise encompasses designing and coordinating studies, including managing advanced-stage bladder, prostate, and kidney cancer trials. As a principal investigator designee, he has effectively led trials from inception to completion, ensuring adherence to Good Clinical Practice (GCP) and regulatory standards. His research capabilities are further evidenced by his Ph.D. in Oncology, focusing on high-risk upper tract urinary cancer, which underscores his in-depth knowledge and specialized skills. Maksym has presented his research at numerous international conferences, showcasing his ability to communicate complex findings effectively. His experience with electronic medical record systems and his multilingual proficiency enhance his ability to collaborate with diverse research teams and access a broad spectrum of scientific resources. Overall, his research skills reflect a strong commitment to advancing medical knowledge and improving patient outcomes.

Award and Recognition

Maksym Pikul has garnered significant recognition for his contributions to the fields of urology and oncology. His dedication to advancing medical practice through research has been acknowledged at numerous international forums, where he has presented his work at prominent conferences such as the EAU Congress and the ASCO GU Conference. His research into high-risk upper tract urinary cancer has been well-regarded, showcasing his commitment to pioneering new treatments and improving patient outcomes. Maksym’s role in managing multiple clinical trials, including advanced stages of bladder, prostate, and kidney cancer, highlights his expertise and leadership in clinical research. His active participation in global scientific communities and ongoing education further exemplify his dedication to advancing medical knowledge and practice. These achievements reflect his significant impact on the field and underscore his suitability for prestigious awards and recognition in his area of expertise.

Conclusion

Maksym Pikul is a highly qualified candidate for the Research for Best Researcher Award, showcasing a robust combination of clinical expertise, research experience, and international engagement. His contributions to clinical trials and oncology research are notable, but to enhance his candidacy, he should focus on increasing his publication record, showcasing the impact of his research, and highlighting any leadership or mentorship roles. Strengthening these areas will provide a more comprehensive view of his contributions and impact in the field of urology and oncology.

Publication Top Notes

  1. Title: Comparison of Aggressiveness in Central Versus Peripheral T1a Clear-Cell Renal Cell Carcinoma
    • Authors: Semko, S.L., Voylenko, O.A., Pikul, M.V., Stakhovsky, E.O., Hrechko, B.
    • Year: 2024
    • Journal: Urologic Oncology: Seminars and Original Investigations
    • Volume: 42
    • Issue: 2
    • Pages: 31.e9–31.e15
    • Citations: 1
  2. Title: Advantages of Organ-Sparing Treatment Approaches in Metastatic Kidney Cancer
    • Authors: Vitruk, I., Voylenko, O., Stakhovsky, O., Koshel, D., Stakhovsky, E.
    • Year: 2023
    • Journal: Journal of Cancer Research and Clinical Oncology
    • Volume: 149
    • Issue: 7
    • Pages: 3131–3137
    • Citations: 1
  3. Title: Modification of Fast-Track Surgery During Partial Nephrectomy
    • Authors: Voylenko, O.A., Pikul, M.V., Semko, S.L., Vitruk, I.V., Stakhovskyi, E.O.
    • Year: 2023
    • Journal: Ukrainian Journal of Nephrology and Dialysis
    • Volume: 80
    • Issue: 4
    • Pages: 24–33
  4. Title: Efficacy of Combined Organ-Sparing Management of Invasive Upper Urinary Tract Urothelial Carcinoma
    • Authors: Pikul, M.V., Stakhovsky, E.O.
    • Year: 2023
    • Journal: Central European Journal of Urology
    • Volume: 76
    • Issue: 2
    • Pages: 116–122
  5. Title: Effects of Tumor and Concomitant Pathology on Morpho-Functional Changes in the Kidneys
    • Authors: Krotevych, M., Trokhymych, S.S., Koshubarova, M.V., Stakhovskyi, E.O., Pasichnyk, S.M.
    • Year: 2022
    • Journal: Experimental Oncology
    • Volume: 44
    • Issue: 1
    • Pages: 166–172
  6. Title: Evaluation of Response to Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Patients Based on Expression of miR-99b, -144, -210, -222, -302a, and -377 in Tumor Tissue
    • Authors: Vitruk, Yu.V., Semko, S.L., Voylenko, O.A., Stakhovsky, E.O., Rossylna, O.V.
    • Year: 2021
    • Journal: Experimental Oncology
    • Volume: 43
    • Issue: 2
    • Pages: 98–103
    • Citations: 1
  7. Title: Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localized Clear-Cell Renal Cell Carcinoma
    • Authors: Voylenko, O.A., Stakhovsky, O.E., Vitruk, I.V., Semko, S.L., Stakhovsky, E.O.
    • Year: 2021
    • Journal: Advances in Urology
    • Volume: 2021
    • Article ID: 6674637
    • Citations: 6
  8. Title: Quality of Life in Patients After Radical Cystectomy with Modified Ureterocutaneostomy and Bricker Urinary Diversion
    • Authors: Stakhovskyi, O.E., Semko, S.L., Pikul, M.V., Vitruk, I.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Experimental Oncology
    • Volume: 42
    • Issue: 3
    • Pages: 224–227
    • Citations: 3
  9. Title: Transperitoneal Uretercutaneostomy with Use of Mesosigmoid Colon Peritoneum in Patients with Bladder Cancer After Radical Cystectomy
    • Authors: Stakhovskyi, O.E., Pikul, M.V., Semko, S.L., Grechko, B.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Wiadomosci Lekarskie (Warsaw, Poland: 1960)
    • Volume: 73
    • Issue: 5
    • Pages: 988–993
  10. Title: A Case of Synchronous Bilateral Calyx Urothelial Carcinoma: Combined Treatment Approach
    • Authors: Semko, S., Pikul, M., Voylenko, O., Vitruk, Yu., Stakhovsky, E.
    • Year: 2019
    • Journal: Experimental Oncology
    • Volume: 41
    • Issue: 1
    • Pages: 76–79